These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 28248952)
1. Patient-derived xenografts as in vivo models for research in urological malignancies. Inoue T; Terada N; Kobayashi T; Ogawa O Nat Rev Urol; 2017 May; 14(5):267-283. PubMed ID: 28248952 [TBL] [Abstract][Full Text] [Related]
2. Patient-derived tumour models for personalized therapeutics in urological cancers. van de Merbel AF; van der Horst G; van der Pluijm G Nat Rev Urol; 2021 Jan; 18(1):33-45. PubMed ID: 33173206 [TBL] [Abstract][Full Text] [Related]
3. Patient-derived xenograft models for personalized medicine in colorectal cancer. Xie J; Lin Y Clin Exp Med; 2020 May; 20(2):167-172. PubMed ID: 32100151 [TBL] [Abstract][Full Text] [Related]
4. Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development. Philp LK Methods Mol Biol; 2024; 2806():153-185. PubMed ID: 38676802 [TBL] [Abstract][Full Text] [Related]
5. Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments. Zarzosa P; Navarro N; Giralt I; Molist C; Almazán-Moga A; Vidal I; Soriano A; Segura MF; Hladun R; Villanueva A; Gallego S; Roma J Clin Transl Oncol; 2017 Jan; 19(1):44-50. PubMed ID: 27718156 [TBL] [Abstract][Full Text] [Related]
6. Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification. Oh DY; Jung K; Song JY; Kim S; Shin S; Kwon YJ; Oh E; Park WY; Song SY; Choi YL BMC Cancer; 2017 Aug; 17(1):535. PubMed ID: 28806950 [TBL] [Abstract][Full Text] [Related]
7. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts. Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A Cells; 2019 Jun; 8(6):. PubMed ID: 31207870 [TBL] [Abstract][Full Text] [Related]
8. Patient-derived xenograft models in musculoskeletal malignancies. Lu W; Chao T; Ruiqi C; Juan S; Zhihong L J Transl Med; 2018 Apr; 16(1):107. PubMed ID: 29688859 [TBL] [Abstract][Full Text] [Related]
9. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research. Jung J; Seol HS; Chang S Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551 [TBL] [Abstract][Full Text] [Related]
10. Applications of patient-derived tumor xenograft models and tumor organoids. Yoshida GJ J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904 [TBL] [Abstract][Full Text] [Related]
12. Generation and application of patient-derived xenograft models in pancreatic cancer research. Wang CF; Shi XJ Chin Med J (Engl); 2019 Nov; 132(22):2729-2736. PubMed ID: 31725451 [TBL] [Abstract][Full Text] [Related]
13. The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development. Palanisamy N; Yang J; Shepherd PDA; Li-Ning-Tapia EM; Labanca E; Manyam GC; Ravoori MK; Kundra V; Araujo JC; Efstathiou E; Pisters LL; Wan X; Wang X; Vazquez ES; Aparicio AM; Carskadon SL; Tomlins SA; Kunju LP; Chinnaiyan AM; Broom BM; Logothetis CJ; Troncoso P; Navone NM Clin Cancer Res; 2020 Sep; 26(18):4933-4946. PubMed ID: 32576626 [TBL] [Abstract][Full Text] [Related]
14. Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer. Wang Y; Cui J; Wang L Chin Clin Oncol; 2019 Apr; 8(2):17. PubMed ID: 30943729 [TBL] [Abstract][Full Text] [Related]
15. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models. Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914 [TBL] [Abstract][Full Text] [Related]
16. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models. Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676 [TBL] [Abstract][Full Text] [Related]
17. Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies. Heo EJ; Cho YJ; Cho WC; Hong JE; Jeon HK; Oh DY; Choi YL; Song SY; Choi JJ; Bae DS; Lee YY; Choi CH; Kim TJ; Park WY; Kim BG; Lee JW Cancer Res Treat; 2017 Oct; 49(4):915-926. PubMed ID: 28052650 [TBL] [Abstract][Full Text] [Related]
18. Patient-Derived Xenografts from Solid Tumors (PDX) for Models of Metastasis. Wulf-Goldenberg A; Hoffmann J; Becker M; Brzezicha B; Walther W Methods Mol Biol; 2021; 2294():43-58. PubMed ID: 33742393 [TBL] [Abstract][Full Text] [Related]
19. Preclinical models for bladder cancer therapy research. Ertl I; Shariat SF; Berger W; Englinger B Curr Opin Urol; 2024 Jul; 34(4):244-250. PubMed ID: 38630912 [TBL] [Abstract][Full Text] [Related]
20. Patient derived xenografts as models for head and neck cancer. Nitschinsk K; Idris A; McMillan N Cancer Lett; 2018 Oct; 434():114-119. PubMed ID: 30031118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]